Lineage Plasticity: The New Cancer Hallmark on the Block.

Cancer research
Authors
Abstract

Plasticity refers to the ability of cells to adopt a spectrum of states or phenotypes. In cancer, it is a critical contributor to tumor initiation, progression, invasiveness, and therapy resistance, and it has recently been recognized as an emerging cancer hallmark. Plasticity can occur as a result of cell-intrinsic factors (e.g., genetic, transcriptional, or epigenetic fluctuations), or through cell-extrinsic cues (e.g., signaling from components of the tumor microenvironment or selective pressure from therapy). Over the past decade, technological advances, analysis of patient samples, and studies in mouse model systems have led to a deeper understanding of how such plastic states come about. In this review, we discuss: (i) the definition of plasticity; (ii) methods to measure and quantify plasticity; (iii) the clinical relevance of plasticity; and (iv) therapeutic hypotheses to modulate plasticity in the clinic.

Year of Publication
2024
Journal
Cancer research
Volume
84
Issue
2
Pages
184-191
Date Published
01/2024
ISSN
1538-7445
DOI
10.1158/0008-5472.CAN-23-1067
PubMed ID
37963209
Links